Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Infrastructure? No Offer Description Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. The disease is triggered by chronic exposure of the respiratory mucosa to noxious
-
laboratory work, analyse data, and contribute to reports and publications. You will also run research clinics for patients with asthma and COPD and work with multidisciplinary collaborators. It is expected
-
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt | Germany | 3 days ago
Health and Immunity (LHI) , we explore the molecular & immunological mechanisms underlying chronic lung diseases such as COPD, lung fibrosis, asthma, lung cancer, and the complications following lung
-
medical ICUs, interstitial lung disease and pulmonary hypertension programs, lung transplantation, interventional pulmonology, cystic fibrosis, asthma and COPD, a rare lung disease program, an NTM clinic
-
of assessment and clinical intervention. Medicine patients are typically admitted with problems such as asthma, Wegners granuloma, COPD, pleural effusion, pulmonary embolus, pneumothorax, pneumonia, sarcoidosis
-
of many respiratory disorders. Established anti-inflammatory medications (e.g. glucocorticosteriods or PDE4 inhibitors) have questionable efficacy in the majority of COPD patients. Patients often suffer
-
lung's lymphatic vasculature in health and disease, with a focus on COPD, through the development of innovative organ-on-chip systems. Description Model development: Collaborate with research partners in
-
be reviewed. Email Questions to: appfellowship@uvahealth.org Please review this link for all steps related to this process: https://virginia.az1.qualtrics.com/jfe/form/SV_8CDNx27eMInHK8S License
-
to support a clinical trial examining the mechanisms underlying the effectiveness of a remotely-delivered Coping Skills Training (CST) intervention for patients with chronic obstructive pulmonary disease (COPD
-
respiratory infections for people with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). The aim is to establish phenotypes of these patients at risk for these infections that could benefit